PMID- 2843766 OWN - NLM STAT- MEDLINE DCOM- 19881021 LR - 20190702 IS - 0027-5107 (Print) IS - 0027-5107 (Linking) VI - 201 IP - 1 DP - 1988 Sep TI - Mutational spectrum and recombinogenic effects induced by aminofluorene adducts in bacteriophage M13. PG - 203-12 AB - Double-stranded replicative form (RFI) DNA of bacteriophage M13 strain M13mp10 which carries partial lacZ gene has been modified in vitro to various extents with N-hydroxy-2-amino-fluorene (N-OH-AF) and then transfected into E. coli cells. High-performance liquid chromatography (HPLC) analysis results demonstrate that the sole adduct (95%) formed in modified DNA is N-(deoxyguanosine-8-yl)-2-aminofluorene (dG-C8-AF). Approximately 20 adducts per RFI molecule constitute 1 lethal event when plaque-forming ability is assayed on E. coli cells which have received no prior SOS induction. The mutagenicity of dG-C8-AF adducts was assayed by measuring loss of beta-galactosidase activity as a function of adducts per molecule. A dose-dependent increase in Lac- mutants was observed, with a 4-fold increase in mutants per survivor at 30 adducts/molecule. The mutations produced, characterized by DNA sequencing, occur predominantly at either G or C positions different from those observed in the spontaneous mutant spectrum. Restriction-mapping results show that in our assay system, dG-C8-AF adducts induce a previously unreported recombinogenic activity. FAU - Ross, J AU - Ross J AD - University of Texas System Cancer Center, Science Park-Research Division, Smithville 78957. FAU - Doisy, R AU - Doisy R FAU - Tang, M S AU - Tang MS LA - eng GR - ES 03124/ES/NIEHS NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - Netherlands TA - Mutat Res JT - Mutation research JID - 0400763 RN - 0 (2-aminofluorene-DNA complex) RN - 0 (Carcinogens) RN - 0 (DNA Adducts) RN - 0 (DNA, Viral) RN - 0 (Fluorenes) RN - 0 (Mutagens) RN - 1D7E8EIA7K (N-(deoxyguanosin-8-yl)-2-aminofluorene) RN - 61M94X4V24 (N-hydroxy-2-aminofluorene) RN - 9007-49-2 (DNA) RN - EC 3.1.21.- (DNA Restriction Enzymes) RN - EC 3.1.21.4 (Deoxyribonucleases, Type II Site-Specific) RN - EC 3.1.21.4 (GGCC-specific type II deoxyribonucleases) RN - G9481N71RO (Deoxyguanosine) SB - IM MH - Bacteriophages/*genetics MH - Base Sequence MH - Carcinogens MH - Chromatography, High Pressure Liquid MH - DNA/*pharmacology MH - *DNA Adducts MH - DNA Restriction Enzymes MH - DNA, Viral/*drug effects/genetics MH - Deoxyguanosine/analogs & derivatives/pharmacology MH - *Deoxyribonucleases, Type II Site-Specific MH - Fluorenes/*pharmacology MH - Molecular Sequence Data MH - Mutagens MH - *Mutation MH - Recombination, Genetic/*drug effects MH - Transfection EDAT- 1988/09/01 00:00 MHDA- 1988/09/01 00:01 CRDT- 1988/09/01 00:00 PHST- 1988/09/01 00:00 [pubmed] PHST- 1988/09/01 00:01 [medline] PHST- 1988/09/01 00:00 [entrez] AID - 0027-5107(88)90127-3 [pii] AID - 10.1016/0027-5107(88)90127-3 [doi] PST - ppublish SO - Mutat Res. 1988 Sep;201(1):203-12. doi: 10.1016/0027-5107(88)90127-3.